Merrill Lynch Remains a Buy on IBM

In a report released yesterday, Wamsi Mohan from Merrill Lynch reiterated a Buy rating on IBM (NYSE: IBM), with a price target of $200. The company’s shares closed yesterday at $169.12. According More »

Chardan Capital Assigns a Buy Rating on Alnylam Pharma

In a report released today, Gbola Amusa from Chardan Capital assigned a Buy rating to Alnylam Pharma (NASDAQ: ALNY). The company’s shares closed yesterday at $123.99. Amusa said: “We now raise our More »